Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002351771 | SCV002653576 | uncertain significance | Cardiovascular phenotype | 2019-11-20 | criteria provided, single submitter | clinical testing | The p.K18403N variant (also known as c.55209G>T), located in coding exon 153 of the TTN gene, results from a G to T substitution at nucleotide position 55209. The lysine at codon 18403 is replaced by asparagine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003138200 | SCV003822170 | uncertain significance | not provided | 2020-10-08 | criteria provided, single submitter | clinical testing |